Scientists unveil more than 600 new tissue models of human cancer
Derived from patient tumor samples and available to researchers around the world, the cells will aid the development of new cancer treatments.
Broad Institute of MIT and Harvard
MIT and Broad Institute researchers break diffraction barrier in super-resolution microscopy
New U-STORM imaging technology lets scientists view molecular structures in subatomic detail — about 1,000 times clearer than traditional dyes — while making the microscope process much simpler.
MIT in the media: Exploring how curiosity-driven science is an essential ingredient in America’s success
“Scientific American” showcases the history and future of America’s scientific engine, highlighting promising young scientists and icons at MIT and beyond.
Myriam Heiman named director of The Picower Institute for Learning and Memory
Heiman, who studies neurodegenerative diseases such as Huntington’s and Parkinson’s, will lead the institute beginning July 1.
Single-molecule tracker illuminates workings of cancer-related proteins
Researchers can now use custom-built microscopy and nanotechnology to tag and follow the activity of individual proteins in real-time.
Big strides in cancer detection and treatment from the tiniest technologies
The MIT Marble Center for Cancer Nanomedicine looks back at 10 years of turning big ideas about nanotechnology into transformative advances for cancer patients.
Enduring passions for medicine, journalism, and triathlons
As an aspiring physician-scientist and editor-in-chief of The Tech, MIT senior Alex Tang has found inspiration in the lives of patients and others in his community.
Lasers, robots, action: MIT workshop explores Raman spectroscopy
Participants learn how laser “fingerprinting” can help identify materials in fields ranging from law enforcement to art restoration.
After 16 years leading Picower Institute, Li-Huei Tsai will sharpen focus on research, teaching
Tsai, who has grown the MIT neuroscience institute, will increase focus on research including Alzheimer’s disease and Down syndrome.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
AI to help researchers see the bigger picture in cell biology
By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
New vaccine platform promotes rare protective B cells
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Cancer’s secret safety net
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.
Richard Hynes, a pioneer in the biology of cellular adhesion, dies at 81
Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.